A Chimeric SERM-Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy

ChemMedChem - United Kingdom
doi 10.1002/cmdc.201300270
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Histone Deacetylase Inhibitors in Cancer Therapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Histone Deacetylase Inhibitor FK228 Enhances Adenovirus-Mediated P53 Family Gene Therapy in Cancer Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer With Low Xist Expression

Clinical Cancer Research
Cancer ResearchOncology
2013English

Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy Against Triple-Negative Human Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2015English

Molecularly Targeted Approach to Cancer Therapy: Design, Synthesis and Biological Activity of Non-Hydroxamate Histone Deacetylase Inhibitors

Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry
Organic Chemistry
2005English

A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma

Oncotarget
Oncology
2016English

A Novel Γ-Lactam-Based Histone Deacetylase Inhibitor Potently Inhibits the Growth of Human Breast and Renal Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy